Beta-1B
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1322 publications
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.
Journal: Health technology assessment (Winchester, England)
Published: August 11, 2026
Host cell protein profiling and immunogenicity assessment in E. coli-produced interferon beta.
Journal: Journal of pharmaceutical sciences
Published: January 30, 2026
Excision of interferon beta-1b-associated plate-like secondary osteoma cutis.
Journal: JAAD case reports
Published: January 19, 2026
LncRNA AFAP1-AS1 mediates therapy-dependent expression of CCL5, CXCL10 and MMP9 in multiple sclerosis.
Journal: Biochemistry and biophysics reports
Published: January 19, 2026
The comparative efficacy of cladribine tablets versus alternative disease-modifying treatments for relapsing-remitting multiple sclerosis: Updated meta-regression estimates by patient subgroup.
Journal: Multiple sclerosis and related disorders
Published: December 20, 2025
The efficacy of disease-modifying therapies in patients with clinically isolated syndrome: a systematic review and network meta-analysis.
Journal: Scientific reports
Published: September 17, 2025
Selected aspects of epidemiology of multiple sclerosis in Poland: a multicenter pilot study.
Journal: Neurologia i neurochirurgia polska
Published: July 21, 2025
Therapeutic evaluation of immunomodulators and immunosuppressants in progressive multiple sclerosis: summary of a Cochrane systematic review.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: June 15, 2025
What Is the Evidence on Immunomodulators and Immunosuppressants for Progressive Multiple Sclerosis? - A Cochrane Review Summary with Commentary.
Journal: NeuroRehabilitation
Published: June 09, 2025
Personality Traits and Their Association With Medication Non-Adherence in Patients With Multiple Sclerosis.
Journal: CNS neuroscience & therapeutics
Published: May 26, 2025
Biophysical insights into pH-induced structural dynamics of recombinant interferon β-1b: Aggregation under acidic conditions.
Journal: International journal of biological macromolecules
Published: February 18, 2025
In brief: Anaphylaxis with glatiramer acetate.
Journal: The Medical letter on drugs and therapeutics
Published: February 13, 2025
Last Updated: 09/26/2026